Skip to main content

J&J Wins California Asbestos Cosmetic Talcum Powder Trial

J&J Wins California Asbestos Cosmetic Talcum Powder Trial

J&J Wins California Asbestos Cosmetic Talcum Powder Trial

Introduction

On Monday, Jurors in California cleared allegations made by a California woman against Johnson & Johnson (J&J) over its talc-based baby powder.

According to the court documents, the 48-year old woman used talcum powder as a child in Hong Kong and also in the U.S after her move in 1984. It further noted that the talc supplied for baby powder from the mines of both Korea and Vermont contained asbestos fibers, which was the reason for her terminal disease.

J&J, in its argument, established that asbestos was not present in the talcum powder using detailed agency's and institutional studies and also outlined the company’s testing protocol that included more than 170,000 test samples of talc and determined the mineral was asbestos-free.

Nearly 14,000 Talcum Powder and Shower-to-Shower lawsuits are consolidated under multidistrict litigation MDL No. 2738; In Re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices, and Products Liability Litigation. Lawsuits are also pending in a coordinated California proceeding under Judicial Council Coordinated Proceeding No. 4877.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Teen E-cigarette Use Hits 10-Year Low

Categories: E-Cigarette: JUUL

Federal officials report a significant decline in teen vaping rates in the U.S., with about half a million fewer middle and high school…

Baltimore, Walgreens Reach Opioid Settlement Totaling $402.5m

Categories: Opioids

The City of Baltimore has reached a settlement with Walgreens over its involvement in the opioid crisis, marking the…

Drug Distributors Reach $300M Opioid Settlement

Categories: Opioids

The three largest U.S. drug distributors—McKesson Corp, Cencora Inc, and Cardinal Health Inc—have agreed to pay $300 million to settle claims by health insurers and benefit plans over their role in fueling the U.S.…

Labor Day Litigation Bonanza!     
Free Trials + 15% Discount!